Renaissance Capital logo

LSF News

US IPO Weekly Recap: Health and tech dominate the calendar in an 11 IPO week

GDRX

September activity remained high as 11 IPOs and eight SPACs went public this past week. The IPO market shows no signs of slowing with eight IPOs and 18 SPACS submitting initial filings. Prescription drug price comparison platform GoodRx (GDRX) priced well above the range to raise $1.1 billion at a $14.2 billion market cap. The company provides one of the...read more

Plant-based beverage manufacturer Laird Superfood prices IPO at $22, the high end of the upwardly revised range

LSF

Laird Superfood, which manufactures plant-based packaged beverage products, raised $58 million by offering 2.7 million shares at $22, the high end of the upwardly revised range of $21 to $22. The company originally planned to offer 2.2 million shares at $18 to $20 before increasing its deal size on Tuesday morning. At pricing, the company commands a fully diluted market value of...read more

US IPO Week Ahead: The September IPO calendar stays Good(Rx) and busy in an 8 IPO week

GP

In another busy week for the September IPO market, eight IPOs are scheduled to raise $2.0 billion, led by prescription drug marketplace GoodRx Holdings (GDRX).  The largest deal of the week, GoodRx (GDRX) plans to raise $900 million at an $11.2 billion market cap. The company operates in the large prescription drug...read more

Plant-based beverage manufacturer Laird Superfood sets terms for $42 million IPO

LSF

Laird Superfood, which manufactures plant-based packaged beverage products, announced terms for its IPO on Tuesday. The Sisters, OR-based company plans to raise $42 million by offering 2.2 million shares at a price range of $18 to $20. The company may also raise an additional $10 million in a concurrent private placement to Danone Manifesto Ventures. At the midpoint...read more